Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00701_DB00706> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00701_DB00706 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00701_DB00706 label "DDI between Amprenavir and Tamsulosin - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Amprenavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00701_DB00706]" assertion.
- drugbank_resource:DB00701_DB00706 identifier "drugbank_resource:DB00701_DB00706" assertion.
- drugbank_resource:DB00701_DB00706 title "DDI between Amprenavir and Tamsulosin - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Amprenavir is initiated, discontinued, or dose changed." assertion.